Extreme concentrations of endogenous sex hormones, ischemic heart disease, and death in women

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Extreme concentrations of endogenous sex hormones, ischemic heart disease, and death in women. / Benn, Marianne; Voss, Sidsel Skou; Holmegard, Haya N.; Jensen, Gorm B.; Tybjærg-Hansen, Anne; Nordestgaard, Børge G.

In: Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 35, No. 2, 02.02.2015, p. 471-477.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Benn, M, Voss, SS, Holmegard, HN, Jensen, GB, Tybjærg-Hansen, A & Nordestgaard, BG 2015, 'Extreme concentrations of endogenous sex hormones, ischemic heart disease, and death in women', Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 35, no. 2, pp. 471-477. https://doi.org/10.1161/ATVBAHA.114.304821

APA

Benn, M., Voss, S. S., Holmegard, H. N., Jensen, G. B., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2015). Extreme concentrations of endogenous sex hormones, ischemic heart disease, and death in women. Arteriosclerosis, Thrombosis, and Vascular Biology, 35(2), 471-477. https://doi.org/10.1161/ATVBAHA.114.304821

Vancouver

Benn M, Voss SS, Holmegard HN, Jensen GB, Tybjærg-Hansen A, Nordestgaard BG. Extreme concentrations of endogenous sex hormones, ischemic heart disease, and death in women. Arteriosclerosis, Thrombosis, and Vascular Biology. 2015 Feb 2;35(2):471-477. https://doi.org/10.1161/ATVBAHA.114.304821

Author

Benn, Marianne ; Voss, Sidsel Skou ; Holmegard, Haya N. ; Jensen, Gorm B. ; Tybjærg-Hansen, Anne ; Nordestgaard, Børge G. / Extreme concentrations of endogenous sex hormones, ischemic heart disease, and death in women. In: Arteriosclerosis, Thrombosis, and Vascular Biology. 2015 ; Vol. 35, No. 2. pp. 471-477.

Bibtex

@article{a92ffeea0f35477189badb75a56bbb0f,
title = "Extreme concentrations of endogenous sex hormones, ischemic heart disease, and death in women",
abstract = "OBJECTIVE - : Sex hormones may be critical determinants of ischemic heart disease and death in women, but results from previous studies are conflicting. To clarify this, we tested the hypothesis that extreme plasma concentrations of endogenous estradiol and testosterone are associated with risk of ischemic heart disease and death in women. APPROACH AND RESULTS - : In a nested prospective cohort study, we measured plasma estradiol in 4600 and total testosterone in 4716 women not receiving oral contraceptives or hormonal replacement therapy from the 1981 to 1983 examination of the Copenhagen City Heart Study. During ≤30 years of follow-up, 1013 women developed ischemic heart disease and 2716 died. In women with a plasma estradiol below the fifth percentile compared with between the 10th and 89th percentiles, multifactorially adjusted risk of ischemic heart disease was 44% (95% confidence interval, 14%-81%) higher; however, plasma estradiol concentrations did not associate with death. Also, in women with a plasma testosterone concentration at or above the 95th percentile compared with between the 10th and 89th percentiles, multifactorially adjusted risk was 68% (34%-210%) higher for ischemic heart disease, 36% (18%-58%) higher for any death, and 38% (15%-65%) higher for death from other causes than cardiovascular disease and cancer. These results were similar for postmenopausal women alone. CONCLUSIONS - : In women, extreme low concentrations of endogenous estradiol were associated with high risk of ischemic heart disease, and extreme high concentrations of endogenous testosterone were associated with high risk of ischemic heart disease and death.",
keywords = "death, epidemiology, estrogens, general social development and population, gonadal steroid hormones, myocardial infarction, myocardial ischemia, testosterone",
author = "Marianne Benn and Voss, {Sidsel Skou} and Holmegard, {Haya N.} and Jensen, {Gorm B.} and Anne Tybj{\ae}rg-Hansen and Nordestgaard, {B{\o}rge G.}",
year = "2015",
month = feb,
day = "2",
doi = "10.1161/ATVBAHA.114.304821",
language = "English",
volume = "35",
pages = "471--477",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams & Wilkins",
number = "2",

}

RIS

TY - JOUR

T1 - Extreme concentrations of endogenous sex hormones, ischemic heart disease, and death in women

AU - Benn, Marianne

AU - Voss, Sidsel Skou

AU - Holmegard, Haya N.

AU - Jensen, Gorm B.

AU - Tybjærg-Hansen, Anne

AU - Nordestgaard, Børge G.

PY - 2015/2/2

Y1 - 2015/2/2

N2 - OBJECTIVE - : Sex hormones may be critical determinants of ischemic heart disease and death in women, but results from previous studies are conflicting. To clarify this, we tested the hypothesis that extreme plasma concentrations of endogenous estradiol and testosterone are associated with risk of ischemic heart disease and death in women. APPROACH AND RESULTS - : In a nested prospective cohort study, we measured plasma estradiol in 4600 and total testosterone in 4716 women not receiving oral contraceptives or hormonal replacement therapy from the 1981 to 1983 examination of the Copenhagen City Heart Study. During ≤30 years of follow-up, 1013 women developed ischemic heart disease and 2716 died. In women with a plasma estradiol below the fifth percentile compared with between the 10th and 89th percentiles, multifactorially adjusted risk of ischemic heart disease was 44% (95% confidence interval, 14%-81%) higher; however, plasma estradiol concentrations did not associate with death. Also, in women with a plasma testosterone concentration at or above the 95th percentile compared with between the 10th and 89th percentiles, multifactorially adjusted risk was 68% (34%-210%) higher for ischemic heart disease, 36% (18%-58%) higher for any death, and 38% (15%-65%) higher for death from other causes than cardiovascular disease and cancer. These results were similar for postmenopausal women alone. CONCLUSIONS - : In women, extreme low concentrations of endogenous estradiol were associated with high risk of ischemic heart disease, and extreme high concentrations of endogenous testosterone were associated with high risk of ischemic heart disease and death.

AB - OBJECTIVE - : Sex hormones may be critical determinants of ischemic heart disease and death in women, but results from previous studies are conflicting. To clarify this, we tested the hypothesis that extreme plasma concentrations of endogenous estradiol and testosterone are associated with risk of ischemic heart disease and death in women. APPROACH AND RESULTS - : In a nested prospective cohort study, we measured plasma estradiol in 4600 and total testosterone in 4716 women not receiving oral contraceptives or hormonal replacement therapy from the 1981 to 1983 examination of the Copenhagen City Heart Study. During ≤30 years of follow-up, 1013 women developed ischemic heart disease and 2716 died. In women with a plasma estradiol below the fifth percentile compared with between the 10th and 89th percentiles, multifactorially adjusted risk of ischemic heart disease was 44% (95% confidence interval, 14%-81%) higher; however, plasma estradiol concentrations did not associate with death. Also, in women with a plasma testosterone concentration at or above the 95th percentile compared with between the 10th and 89th percentiles, multifactorially adjusted risk was 68% (34%-210%) higher for ischemic heart disease, 36% (18%-58%) higher for any death, and 38% (15%-65%) higher for death from other causes than cardiovascular disease and cancer. These results were similar for postmenopausal women alone. CONCLUSIONS - : In women, extreme low concentrations of endogenous estradiol were associated with high risk of ischemic heart disease, and extreme high concentrations of endogenous testosterone were associated with high risk of ischemic heart disease and death.

KW - death

KW - epidemiology

KW - estrogens

KW - general social development and population

KW - gonadal steroid hormones

KW - myocardial infarction

KW - myocardial ischemia

KW - testosterone

UR - http://www.scopus.com/inward/record.url?scp=84922062748&partnerID=8YFLogxK

U2 - 10.1161/ATVBAHA.114.304821

DO - 10.1161/ATVBAHA.114.304821

M3 - Journal article

C2 - 25550203

AN - SCOPUS:84922062748

VL - 35

SP - 471

EP - 477

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 2

ER -

ID: 178794249